t01 |
infection, cell(s), immune, response(s), expression, viral, role, inflammatory |
288 |
6 |
t02 |
influenza, lung, respiratory, severe, ARDS, sars-cov, mers-cov, H5N1, viruses, SARS |
72 |
1 |
t03 |
group, rats, significantly, injury, HC, survival_rate, staining, lung, HCP, treatment |
52 |
0 |
t04 |
patients, =, IP-10, healthy, <, children, cytokine, pbmcs, RANTES, levels |
42 |
1 |
t05 |
MHV3, A/J, mice, MHV, resistant, balb/c, strains, mouse, virus, a/j_mice |
42 |
0 |
t06 |
CNS, brain, CCL2, chemokine, CXCL10, CCR2, nervous, encephalitis, CCR5, demyelination |
46 |
0 |
t07 |
lung, airway(s), inflammation, PTX3, allergic, lavage, fluid, chronic, RSV |
37 |
0 |
t08 |
oxide, nitric, macrophage(s), nitric_oxide, polarization, M1, RAW, YPFS, effects |
42 |
0 |
t09 |
nf-κb, MAPK, inflammasome, p38, phosphorylation, ams, NLRP3, skin, TREM‐1, nuclear |
40 |
0 |
t10 |
endothelial, mscs, CD13, leukocytes, cells, epithelial, II, class, TI, adhesion |
35 |
0 |
t11 |
liver, hepatitis, hepatic, MHV-3, IL-33, fulminant, liver_injury, hepatocyte(s), HCV |
39 |
0 |
t12 |
pig(s), PRRSV, porcine, PRCV, swine, reproductive, ifn-α, IL6, prrsv-induced |
30 |
0 |
t13 |
HMGB1, sepsis, transgenic, ACE2, GL, transgenic_mice, angiotensin, ang, box, II |
32 |
0 |
t14 |
FIP, cats, feline, CHIKV, LTB4, FIPV, PRV, HIV‐1, peritonitis, vascular |
31 |
0 |
t15 |
complement, storm, cytokine_storm, COVID-19, c5a, EBOV, complement_activation, pneumococcal, C3, sars-cov-2 |
21 |
6 |